英格兰炎症性肠病患者阿片类药物处方增加与死亡率的关系
该回顾性队列研究利用英格兰初级保健数据库ResearchOne,纳入3517例克罗恩病和5349例溃疡性结肠炎患者,分析1990年至2014年9月14日阿片类药物处方趋势及其与全因死亡率的关联。结果显示阿片类药物处方从1990-1993年的10%升至2010-2013年的30%(趋势卡方检验P<.005),强阿片类药物的重度使用与克罗恩病和溃疡性结肠炎患者的全因早死率增加相关。
要点
- 阿片类药物处方率从1990-1993年的10%上升至2010-2013年的30%(趋势卡方检验P<.005)。
- 强阿片类药物重度使用与克罗恩病患者的早死率增加显著相关。
- 强阿片类药物中度或重度使用与溃疡性结肠炎患者的早死率增加显著相关。
核心结论
- 在英格兰炎症性肠病初级保健患者中,阿片类药物处方从1990年至2013年显著增加。
- 炎症性肠病患者中强阿片类药物的重度使用与全因早死率增加相关。
研究设计与样本
- 纳入3517例克罗恩病患者和5349例溃疡性结肠炎患者,分析1990年至2014年9月14日期间阿片类药物处方趋势,并用倾向评分匹配分析阿片类药物与全因死亡率的关联。
主要发现
- 阿片类药物处方率从1990-1993年的10%上升至2010-2013年的30%(趋势卡方检验P<.005)。
- 强阿片类药物重度使用与克罗恩病患者早死率增加显著相关。
- 强阿片类药物中度或重度使用与溃疡性结肠炎患者早死率增加显著相关。
- 任何阿片类药物或可待因单独的重度使用与溃疡性结肠炎患者早死率增加显著相关。
- 曲马多单独使用或与可待因联合使用与克罗恩病或溃疡性结肠炎患者早死率无显著关联。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The prescription of opiate medications is increasing. Individuals with inflammatory bowel diseases (IBD) can develop serious complications from opiate use, but few data are available on the prescription of these drugs to patients with IBD. We examined trends in prescriptions of opiates and their association with all-cause mortality in individuals with IBD. METHODS: We performed a retrospective cohort study of 3517 individuals with Crohn's disease (CD) and 5349 with ulcerative colitis (UC) using the primary care database ResearchOne, which holds de-identified clinical and administrative information from the health records of approximately 6 million persons (more than 10% of the total population) in England. We explored trends in prescriptions of all opiates, codeine, tramadol, or strong opiates, separately from 1990 through September 14, 2014. Associations between opiates and all-cause mortality were examined using propensity score-matched analysis. RESULTS: There was a statistically significant increase in the prescription of opiate medications, with 10% of subjects receiving an opiate prescription from 1990 through 1993 compared to 30% from 2010 through 2013 (chi-square for trend, P < .005). Prescription of strong opiates was significantly associated with increased premature mortality of patients with CD (heavy use) or UC (moderate or heavy use). There was a significant association between heavy use of any opiate or codeine alone and premature mortality of patients with UC. Use of tramadol alone, or in combination with codeine, was not associated with premature mortality in patients with CD or UC. CONCLUSIONS: In an analysis of primary care patients with IBD in England, we found prescriptions for opiate drugs to have increased significantly from 1990 through 2013. Heavy use of strong opiates among patients with IBD associates with increased all-cause premature mortality.
引用
- Burr NE, Smith C, West R, et al. Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England. Clin Gastroenterol Hepatol. 2017. PMID: 29079223. doi:10.1016/j.cgh.2017.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。